Trends in United States ovarian cancer mortality, 1979-1995

Obstetrics and Gynecology

Volumn 93, Issue 1, 1999, Pages 30-33

  Oriel, Kathleen A ^a,b   Hartenbach, Ellen M ^a   Remington, Patrick L ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; FEMALE; HUMAN; MIDDLE AGED; MORTALITY; OVARY TUMOR; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; UNITED STATES;

EID: 0032608651     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00397-4     Document Type: Article

References (14)

1. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995;45:8-30.
2. Tortolero-Luna G, Mitchell MF, Rhodes-Morris HE. Epidemiology and screening of ovarian cancer. Obstet Gynecol Clin North Am 1994;21:1-23.
3. NIH Consensus Development Panel on Ovarian Cancer. Ovarian cancer: Screening, treatment, and follow-up. JAMA 1996;273:491-7.
4. Qazi F, McGuire WP. Treatment of epithelial ovarian cancer. CA Cancer J Clin 1995;45:88-101.
5. Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK, eds. SEER cancer statistics review: 1973-1994, National Cancer Institute. NIH publication no. 97-2789. Bethesda, Maryland: NIH, 1997.
6. Averette HE, Janicek MF, Menck HR. The national cancer data base report on ovarian cancer. Cancer 1995;76:1096-103.
7. Adami HO, Bergstrom R, Persson I, Sparen P. The incidence of ovarian cancer in Sweden, 1960-1984. Am J Epidemiol 1990;132: 446-52.
8. Hanai A. Trends and differentials in ovarian cancer: Incidence, mortality, and survival experience. APMIS 1990;12:1-20.
9. Villard-Mackintosh L, Vessey MP, Jones L. The effects of oral contraceptives and parity on ovarian cancer trends in women under 55 years of age. Br J Obstet Gynaecol 1989;96:783-8.
10. Silva IS, Swerdlow AJ. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancer in England and Wales and their relation to changing fertility and oral contraceptive use. Br J Cancer 1995;72:485-92.
11. Ewertz M, Kjaer SK. Ovarian cancer incidence and mortality in Denmark, 1943-1982. Int J Cancer 1988;42:690-6.
12. Williams S, Blessing JA, Liao SY, Ball H, Hanjani P. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: A trial of the Gynecologic Oncology Group. J Clin Oncol 1994;12:701-6.
13. Gershenson DM. Management of early ovarian cancer: Germ cell and sex cord-stromal tumors. Gynecol Oncol 1994;55:S62-72.
14. Ries LAG. Ovarian cancer: Survival and treatment difference by age. Cancer 1993;71(2 Suppl):524-9.